GlassScriptPhysician profile
Tara E Scott White
NPI 1508866799
$1,126.55
in general payments reported to CMS, 2019-2025
16 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $112 · 2023: $207 · 2024: $366 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $375.45 | 2021-2025 | |
| Amgen INC. | $145.74 | 2021-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $135.97 | 2021-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.65 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $57.77 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.92 | 2022-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $37.01 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.43 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $30.72 | 2021-2025 | Camzyos |
| Heartflow, INC. | $22.42 | 2024 | |
| Sanofi-Aventis U.S. LLC | $22.24 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $20.69 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $18.82 | 2021 | |
| Chiesi USA, INC. | $18.35 | 2021 | |
| Merck Sharp & Dohme LLC | $18.05 | 2023 | Verquvo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $17.32 | 2024 | Opsumit, Uptravi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Scott White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.